HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshiaki Tanaka Selected Research

TRK 820

11/2012In vitro and in vivo pharmacological characterization of the main metabolites of nalfurafine hydrochloride.
10/2004Possible pharmacotherapy of the opioid kappa receptor agonist for drug dependence.
4/2004Suppression of acute herpetic pain-related responses by the kappa-opioid receptor agonist (-)-17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-beta-[n-methyl-3-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (TRK-820) in mice.
1/2002Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshiaki Tanaka Research Topics

Disease

101Neoplasms (Cancer)
01/2024 - 11/2002
45Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 06/2006
39Neoplasm Metastasis (Metastasis)
04/2022 - 11/2002
36Rectal Neoplasms (Rectal Cancer)
04/2022 - 04/2006
20Renal Cell Carcinoma (Grawitz Tumor)
01/2024 - 12/2003
18Lymphatic Metastasis
06/2021 - 05/2003
16Esophageal Neoplasms (Esophageal Cancer)
07/2023 - 11/2002
16Ulcerative Colitis
07/2022 - 01/2007
15Carcinoma (Carcinomatosis)
05/2024 - 12/2002
11Urinary Bladder Neoplasms (Bladder Cancer)
01/2024 - 12/2009
11Prostatic Neoplasms (Prostate Cancer)
07/2021 - 03/2008
10Colonic Neoplasms (Colon Cancer)
05/2019 - 06/2016
9Turner Syndrome (Turner's Syndrome)
01/2020 - 10/2006
8Hemorrhage
01/2022 - 11/2010
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020 - 01/2003
7Hepatocellular Carcinoma (Hepatoma)
11/2013 - 11/2004
6Inflammation (Inflammations)
03/2024 - 02/2015
6Adenocarcinoma
04/2022 - 03/2015
6Carcinogenesis
01/2021 - 07/2008
6Peritoneal Neoplasms
01/2019 - 11/2015
6Infections
01/2019 - 10/2009
5Disease Progression
04/2022 - 11/2015
5Acute Kidney Injury (Acute Renal Failure)
05/2020 - 01/2016
4Hydronephrosis
01/2024 - 06/2004
4Pathologic Constriction (Stenosis)
10/2023 - 06/2004
4Obesity
01/2022 - 01/2005
4Fever (Fevers)
05/2021 - 11/2002
4Hypoxia (Hypoxemia)
01/2020 - 05/2011
4Type 2 Diabetes Mellitus (MODY)
03/2019 - 01/2005
4Anastomotic Leak
05/2018 - 05/2003
4Hypogonadism (Hypergonadotropic Hypogonadism)
04/2015 - 06/2004
4Testicular Neoplasms (Testicular Cancer)
07/2013 - 06/2003
3Hyperplasia
11/2023 - 06/2006
3Microsatellite Instability
11/2023 - 06/2006
3Pain (Aches)
10/2023 - 04/2004
3Chronic Renal Insufficiency
07/2022 - 07/2013
3Pituitary Dwarfism
02/2022 - 09/2007

Drug/Important Bio-Agent (IBA)

15Growth Hormone (Somatotropin)IBA
02/2022 - 02/2003
11DNA (Deoxyribonucleic Acid)IBA
01/2020 - 02/2003
11Proteins (Proteins, Gene)FDA Link
03/2019 - 10/2004
9Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2015 - 11/2004
8Cisplatin (Platino)FDA LinkGeneric
11/2023 - 11/2002
7Biomarkers (Surrogate Marker)IBA
10/2021 - 09/2014
7Glucose (Dextrose)FDA LinkGeneric
03/2019 - 04/2004
7Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 11/2002
6Indicators and Reagents (Reagents)IBA
04/2023 - 05/2015
6Human Growth Hormone (Saizen)FDA LinkGeneric
11/2022 - 02/2003
6AndrogensIBA
06/2021 - 01/2004
6SteroidsIBA
02/2021 - 06/2015
6Carcinoembryonic AntigenIBA
05/2019 - 09/2014
5Immune Checkpoint InhibitorsIBA
03/2024 - 11/2017
5NivolumabIBA
04/2022 - 08/2017
5Sunitinib (Sutent)FDA Link
04/2022 - 01/2017
5Transcription Factors (Transcription Factor)IBA
01/2021 - 06/2013
5Anti-Bacterial Agents (Antibiotics)IBA
05/2020 - 01/2016
5Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2019 - 09/2015
5Irinotecan (Camptosar)FDA LinkGeneric
06/2018 - 01/2016
5AntigensIBA
05/2017 - 11/2008
4Aldehyde Dehydrogenase 1 FamilyIBA
01/2021 - 01/2013
4Hormones (Hormone)IBA
01/2020 - 06/2004
4Insulin (Novolin)FDA Link
03/2019 - 04/2004
4Testosterone (Sustanon)FDA Link
01/2019 - 01/2007
4Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 06/2011
4Messenger RNA (mRNA)IBA
07/2018 - 01/2011
4CreatinineIBA
10/2017 - 06/2004
4Monoclonal AntibodiesIBA
08/2017 - 12/2009
4PalmitatesIBA
06/2017 - 05/2008
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2015 - 02/2006
4TRK 820IBA
11/2012 - 01/2002
3pembrolizumabIBA
03/2024 - 01/2022
3Etoposide (VP 16)FDA LinkGeneric
11/2023 - 02/2006
3Axitinib (AG 013736)IBA
04/2022 - 11/2018
3GemcitabineFDA Link
01/2022 - 10/2018
3AlbuminsIBA
02/2021 - 01/2019

Therapy/Procedure

60Therapeutics
05/2024 - 04/2006
39Drug Therapy (Chemotherapy)
05/2024 - 11/2002
25Chemoradiotherapy
05/2021 - 07/2003
21Lymph Node Excision (Lymph Node Dissection)
04/2022 - 01/2003
17Esophagectomy
12/2023 - 11/2002
14Neoadjuvant Therapy
01/2021 - 12/2009
11Cystectomy
01/2024 - 12/2009
11Radiotherapy
10/2023 - 11/2003
10Adjuvant Chemotherapy
09/2022 - 01/2003
9Nephrectomy
01/2024 - 12/2003
9Colectomy
07/2021 - 04/2015
7Restorative Proctocolectomy
07/2022 - 01/2015
6Urinary Diversion (Ileal Conduit)
01/2024 - 07/2004
6Immunotherapy
04/2022 - 11/2002
5Nephroureterectomy
10/2023 - 12/2012
5Stents
10/2023 - 05/2004
5Castration
06/2021 - 04/2013
5Aftercare (After-Treatment)
10/2020 - 06/2003
4Kidney Transplantation
01/2022 - 10/2009
4Renal Dialysis (Hemodialysis)
05/2020 - 11/2012
4Ileostomy
08/2019 - 11/2017
4Length of Stay
01/2018 - 01/2016
4Prostatectomy (Retropubic Prostatectomy)
06/2017 - 09/2010
3Urinary Catheters
02/2024 - 01/2016
3Injections
01/2022 - 04/2004
3Catheters
01/2022 - 07/2004